BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32574835)

  • 1. Pathways involved in viral oncogenesis: New perspectives from virus-host protein interactomics.
    Kori M; Arga KY
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165885. PubMed ID: 32574835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenic Role of Tumor Viruses in Humans.
    Akram N; Imran M; Noreen M; Ahmed F; Atif M; Fatima Z; Bilal Waqar A
    Viral Immunol; 2017; 30(1):20-27. PubMed ID: 27830995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic Viral Protein Interactions with p53 Family Proteins.
    Brychtová V; Hrabal V; Vojtěšek B
    Klin Onkol; 2019; 32(Supplementum 3):72-77. PubMed ID: 31627709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Promise of Proteomics in the Study of Oncogenic Viruses.
    McBride AA
    Mol Cell Proteomics; 2017 Apr; 16(4 suppl 1):S65-S74. PubMed ID: 28104704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of viral oncogenesis in humans.
    Krump NA; You J
    Nat Rev Microbiol; 2018 Nov; 16(11):684-698. PubMed ID: 30143749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of miRNAs in Virus-Mediated Oncogenesis.
    Vojtechova Z; Tachezy R
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29673190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Viruses in Carcinogenesis and Molecular Targeting: From Infection to Being a Component of the Tumor Microenvironment.
    Dzobo K
    OMICS; 2021 Jun; 25(6):358-371. PubMed ID: 34037476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics of Virus-Induced Tumors: Perspectives for Therapeutic Targeting.
    Vinokurova S
    Curr Pharm Des; 2017; 23(32):4842-4861. PubMed ID: 28828983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human viral oncogenesis: a cancer hallmarks analysis.
    Mesri EA; Feitelson MA; Munger K
    Cell Host Microbe; 2014 Mar; 15(3):266-82. PubMed ID: 24629334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-21: a key modulator in oncogenic viral infections.
    He G; Ding J; Zhang Y; Cai M; Yang J; Cho WC; Zheng Y
    RNA Biol; 2021 May; 18(5):809-817. PubMed ID: 33499700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The AP-1 pathway; A key regulator of cellular transformation modulated by oncogenic viruses.
    Mirzaei H; Khodadad N; Karami C; Pirmoradi R; Khanizadeh S
    Rev Med Virol; 2020 Jan; 30(1):e2088. PubMed ID: 31788897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.
    Saha A; Kaul R; Murakami M; Robertson ES
    Cancer Biol Ther; 2010 Nov; 10(10):961-78. PubMed ID: 21084867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human inborn errors of immunity to oncogenic viruses.
    Béziat V; Jouanguy E
    Curr Opin Immunol; 2021 Oct; 72():277-285. PubMed ID: 34364035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor 1 and its role in viral carcinogenesis.
    Cuninghame S; Jackson R; Zehbe I
    Virology; 2014 May; 456-457():370-83. PubMed ID: 24698149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interpreting cancer genomes using systematic host network perturbations by tumour virus proteins.
    Rozenblatt-Rosen O; Deo RC; Padi M; Adelmant G; Calderwood MA; Rolland T; Grace M; Dricot A; Askenazi M; Tavares M; Pevzner SJ; Abderazzaq F; Byrdsong D; Carvunis AR; Chen AA; Cheng J; Correll M; Duarte M; Fan C; Feltkamp MC; Ficarro SB; Franchi R; Garg BK; Gulbahce N; Hao T; Holthaus AM; James R; Korkhin A; Litovchick L; Mar JC; Pak TR; Rabello S; Rubio R; Shen Y; Singh S; Spangle JM; Tasan M; Wanamaker S; Webber JT; Roecklein-Canfield J; Johannsen E; Barabási AL; Beroukhim R; Kieff E; Cusick ME; Hill DE; Münger K; Marto JA; Quackenbush J; Roth FP; DeCaprio JA; Vidal M
    Nature; 2012 Jul; 487(7408):491-5. PubMed ID: 22810586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between mitochondria and oncoviruses.
    Song S; Gong S; Singh P; Lyu J; Bai Y
    Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):481-487. PubMed ID: 28962899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TLR9 in Oncogenic Virus-Produced Cancer.
    Martínez-Campos C; Burguete-García AI; Madrid-Marina V
    Viral Immunol; 2017 Mar; 30(2):98-105. PubMed ID: 28151089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncoviruses: How do they hijack their host and current treatment regimes.
    Ahmed K; Jha S
    Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188960. PubMed ID: 37507056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities.
    Chowdhary S; Deka R; Panda K; Kumar R; Solomon AD; Das J; Kanoujiya S; Gupta AK; Sinha S; Ruokolainen J; Kesari KK; Gupta PK
    Mol Pharm; 2023 Aug; 20(8):3698-3740. PubMed ID: 37486263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viruses and interactomes in translation.
    Meyniel-Schicklin L; de Chassey B; André P; Lotteau V
    Mol Cell Proteomics; 2012 Jul; 11(7):M111.014738. PubMed ID: 22371486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.